Clinical implications
The present study is among a few studies comparing 4 different minimally
interrupted DOACs. In particular, data on edoxaban is scant. We thus
believe that our findings may be helpful for understanding the
characteristics of each DOAC. Also, the equality of the blood loss
across the 4 DOACs shown in the present study may be of value in terms
of the procedural safety.